This is supported by the fact that DNA hypermethylation at the promoter regions of the BRCA1 gene is associated with its downregulation in nonfamilial breast cancer [18,26] and that inhibition of DNMT activities can prevent the development of breast cancer [30]. This evidence concerns the gene BRCA1 and breast cancer.